- Home
- OSTX vs CYTH Comparison
OSTX vs CYTH Comparison
Compare OSTX & CYTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSTX
- CYTH
- Stock Information
- Founded
- OSTX 2018
- CYTH 1990
- Country
- OSTX United States
- CYTH United States
- Employees
- OSTX N/A
- CYTH N/A
- Industry
- OSTX
- CYTH Biotechnology: Pharmaceutical Preparations
- Sector
- OSTX
- CYTH Health Care
- Exchange
- OSTX NYSE
- CYTH Nasdaq
- Market Cap
- OSTX N/A
- CYTH 31.9M
- IPO Year
- OSTX 2024
- CYTH N/A
- Fundamental
- Price
- OSTX $1.62
- CYTH $0.72
- Analyst Decision
- OSTX Strong Buy
- CYTH Buy
- Analyst Count
- OSTX 2
- CYTH 3
- Target Price
- OSTX $17.50
- CYTH $0.95
- AVG Volume (30 Days)
- OSTX 119.4K
- CYTH 60.8K
- Earning Date
- OSTX 05-15-2025
- CYTH 05-14-2025
- Dividend Yield
- OSTX N/A
- CYTH N/A
- EPS Growth
- OSTX N/A
- CYTH N/A
- EPS
- OSTX N/A
- CYTH N/A
- Revenue
- OSTX N/A
- CYTH $870,725.00
- Revenue This Year
- OSTX N/A
- CYTH N/A
- Revenue Next Year
- OSTX $26,663.99
- CYTH $24.49
- P/E Ratio
- OSTX N/A
- CYTH N/A
- Revenue Growth
- OSTX N/A
- CYTH N/A
- 52 Week Low
- OSTX $1.41
- CYTH $0.55
- 52 Week High
- OSTX $7.00
- CYTH $1.79
- Technical
- Relative Strength Index (RSI)
- OSTX N/A
- CYTH 47.90
- Support Level
- OSTX N/A
- CYTH $0.63
- Resistance Level
- OSTX N/A
- CYTH $0.73
- Average True Range (ATR)
- OSTX 0.00
- CYTH 0.06
- MACD
- OSTX 0.00
- CYTH 0.01
- Stochastic Oscillator
- OSTX 0.00
- CYTH 73.51
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.